FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381548535> ?p ?o ?g. }

• W4381548535 endingPage "e006589" @default.
• W4381548535 startingPage "e006589" @default.
• W4381548535 abstract "Recombinant granulocyte colony-stimulating factor (G-CSF) is routinely administered for prophylaxis or treatment of chemotherapy-induced neutropenia. Chronic myelopoiesis and granulopoiesis in patients with cancer has been shown to induce immature monocytes and neutrophils that contribute to both systemic and local immunosuppression in the tumor microenvironment. The effect of recombinant G-CSF (pegfilgrastim or filgrastim) on the production of myeloid-derived suppressive cells is unknown. Here we examined patients with pancreatic cancer, a disease known to induce myeloid-derived suppressor cells (MDSCs), and for which pegfilgrastim is routinely administered concurrently with FOLFIRINOX but not with gemcitabine-based chemotherapy regimens.Serial blood was collected from patients with pancreatic ductal adenocarcinoma newly starting on FOLFIRINOX or gemcitabine/n(ab)paclitaxel combination chemotherapy regimens. Neutrophil and monocyte frequencies were determined by flow cytometry from whole blood and peripheral blood mononuclear cell fractions. Serum cytokines were evaluated pretreatment and on-treatment. Patient serum was used in vitro to differentiate healthy donor monocytes to MDSCs as measured by downregulation of major histocompatibility complex II (HLA-DR) and the ability to suppress T-cell proliferation in vitro. C57BL/6 female mice with pancreatic tumors were treated with FOLFIRINOX with or without recombinant G-CSF to directly assess the role of G-CSF on induction of immunosuppressive neutrophils.Patients receiving FOLFIRINOX with pegfilgrastim had increased serum G-CSF that correlated with an induction of granulocytic MDSCs. This increase was not observed in patients receiving gemcitabine/n(ab)paclitaxel without pegfilgrastim. Interleukin-18 also significantly increased in serum on FOLFIRINOX treatment. Patient serum could induce MDSCs as determined by in vitro functional assays, and this suppressive effect increased with on-treatment serum. Induction of MDSCs in vitro could be recapitulated by addition of recombinant G-CSF to healthy serum, indicating that G-CSF is sufficient for MDSC differentiation. In mice, neutrophils isolated from spleen of G-CSF-treated mice were significantly more capable of suppressing T-cell proliferation.Pegfilgrastim use contributes to immune suppression in both humans and mice with pancreatic cancer. These results suggest that use of recombinant G-CSF as supportive care, while critically important for mitigating neutropenia, may complicate efforts to induce antitumor immunity." @default.
• W4381548535 created "2023-06-22" @default.
• W4381548535 creator A5001285437 @default.
• W4381548535 creator A5003890551 @default.
• W4381548535 creator A5005140127 @default.
• W4381548535 creator A5007145101 @default.
• W4381548535 creator A5018655814 @default.
• W4381548535 creator A5028547202 @default.
• W4381548535 creator A5039128180 @default.
• W4381548535 creator A5039186159 @default.
• W4381548535 creator A5039476876 @default.
• W4381548535 creator A5043698578 @default.
• W4381548535 creator A5044352034 @default.
• W4381548535 creator A5045249987 @default.
• W4381548535 creator A5045494904 @default.
• W4381548535 creator A5047496278 @default.
• W4381548535 creator A5053848207 @default.
• W4381548535 creator A5061936032 @default.
• W4381548535 creator A5062338114 @default.
• W4381548535 creator A5071684616 @default.
• W4381548535 creator A5075544061 @default.
• W4381548535 creator A5076969910 @default.
• W4381548535 creator A5077382664 @default.
• W4381548535 creator A5090604653 @default.
• W4381548535 creator A5092228643 @default.
• W4381548535 creator A5092228644 @default.
• W4381548535 date "2023-06-01" @default.
• W4381548535 modified "2023-09-26" @default.
• W4381548535 title "G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans" @default.
• W4381548535 cites W1842423069 @default.
• W4381548535 cites W1966522763 @default.
• W4381548535 cites W1969057487 @default.
• W4381548535 cites W2001378959 @default.
• W4381548535 cites W2003870922 @default.
• W4381548535 cites W2008658155 @default.
• W4381548535 cites W2031960993 @default.
• W4381548535 cites W2036450045 @default.
• W4381548535 cites W2038918212 @default.
• W4381548535 cites W2043991982 @default.
• W4381548535 cites W2096099690 @default.
• W4381548535 cites W2109978756 @default.
• W4381548535 cites W2110271242 @default.
• W4381548535 cites W2129176863 @default.
• W4381548535 cites W2151253787 @default.
• W4381548535 cites W2153243639 @default.
• W4381548535 cites W2157612047 @default.
• W4381548535 cites W2158809810 @default.
• W4381548535 cites W2160390319 @default.
• W4381548535 cites W2165480504 @default.
• W4381548535 cites W2166760323 @default.
• W4381548535 cites W2168645047 @default.
• W4381548535 cites W2201948288 @default.
• W4381548535 cites W2298626553 @default.
• W4381548535 cites W2341289486 @default.
• W4381548535 cites W2397703541 @default.
• W4381548535 cites W2411937682 @default.
• W4381548535 cites W2416038770 @default.
• W4381548535 cites W2488076079 @default.
• W4381548535 cites W2749550628 @default.
• W4381548535 cites W2772548919 @default.
• W4381548535 cites W2797407068 @default.
• W4381548535 cites W2810919053 @default.
• W4381548535 cites W289749226 @default.
• W4381548535 cites W2909786746 @default.
• W4381548535 cites W2955530789 @default.
• W4381548535 cites W2959661609 @default.
• W4381548535 cites W2965576600 @default.
• W4381548535 cites W2973724679 @default.
• W4381548535 cites W2984359187 @default.
• W4381548535 cites W3003058300 @default.
• W4381548535 cites W3006033724 @default.
• W4381548535 cites W3007604420 @default.
• W4381548535 cites W3084101009 @default.
• W4381548535 cites W3108152855 @default.
• W4381548535 cites W3112148397 @default.
• W4381548535 cites W3121138383 @default.
• W4381548535 cites W3127051356 @default.
• W4381548535 cites W3153075376 @default.
• W4381548535 cites W3162583084 @default.
• W4381548535 cites W3170389000 @default.
• W4381548535 cites W3170939617 @default.
• W4381548535 cites W4214554632 @default.
• W4381548535 cites W4220741210 @default.
• W4381548535 cites W4225794093 @default.
• W4381548535 cites W4285291978 @default.
• W4381548535 cites W4296711034 @default.
• W4381548535 doi "https://doi.org/10.1136/jitc-2022-006589" @default.
• W4381548535 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37344102" @default.
• W4381548535 hasPublicationYear "2023" @default.
• W4381548535 type Work @default.
• W4381548535 citedByCount "0" @default.
• W4381548535 crossrefType "journal-article" @default.
• W4381548535 hasAuthorship W4381548535A5001285437 @default.
• W4381548535 hasAuthorship W4381548535A5003890551 @default.
• W4381548535 hasAuthorship W4381548535A5005140127 @default.
• W4381548535 hasAuthorship W4381548535A5007145101 @default.
• W4381548535 hasAuthorship W4381548535A5018655814 @default.
• W4381548535 hasAuthorship W4381548535A5028547202 @default.

• next